Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation.
1
Funding Rounds
$23.0m
Money raised
The company Sibylla Biotech has raised a total of $23m in funding over 1 rounds.